Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease

Effects of Coenzyme Q10 in Early Parkinson Disease

Clifford W. Shults · Archives of Neurology · 2002 · 977 citations

Medicine, Pharmacology, Pharmacotherapy +17

An<i>In Vitro</i>Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage

Todd Sherer, Ranjita Betarbet, Amy K. Stout et al. · Journal of Neuroscience · 2002 · 583 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Coenzyme Q ₁₀ administration increases brain mitochondrial concentrations and exerts neuroprotective effects

Russell T. Matthews, Lichuan Yang, Susan Browne et al. · Proceedings of the National Academy of Sciences · 1998 · 559 citations · Full text

Life Sciences, Neuroscience, Pharmacology +15

Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

Richard Haas, Fatemeh Nasirian, Kazutoshi Nakano et al. · Annals of Neurology · 1995 · 436 citations

Life Sciences, Neuroscience, Pharmacology +17

Lovastatin decreases coenzyme Q levels in humans.

Karl Folkers, Peter H. Langsjoen, Richard A. Willis et al. · Proceedings of the National Academy of Sciences · 1990 · 427 citations

Life Sciences, Biochemistry, Pharmacology +16